Denver Hospitals Full With One-In-Four City Residents Infected With Covid
(Bloomberg) -- Denver hospitals are full as one-in-four people who are tested receive positive results amid the worst Covid-19 surge since the pandemic began, said Mayor Michael Hancock, who is recovering from a bout of the virus despite being vaccinated.
Health officials cite the omicron variant for the latest outbreak and are imploring unvaccinated residents to get jabbed to stem the citywide surge and a roughly 25% positivity rate.
Hospitals are facing “the scariest part of the pandemic,” Kathy Howell, chief nursing officer at University of Colorado Hospital, said at a Tuesday news briefing with the mayor and other officials.
Cases are “far exceeding” last year's surge, said Bob McDonald, executive director of the city's department of public health and environment. Capacity is “tapped out” at hospitals, McDonald said, with most hospitalized patients unvaccinated.
Some patients are being transfered to hospitals outside Denver, said Connie Price, chief medical officer at Denver Health, the municipal general hospital.
Howell said the University of Colorado's acute care units are full and intensive care unit capacity for more serious infections, as well as other illnesses and injuries, is 98%.
Price noted patients with omicron have been less likely to require ICU care than in other surges in Denver.
The mayor said he recently tested positive for the virus even though he was vaccinated and received a booster and that he was able to recover at home.
Denver has a mask mandate for public spaces in force until Feb. 3.
There are no plans to close schools, McDonald said. “We are doing everything we can not to disrupt the schools,” he said.
©2022 Bloomberg L.P.
-
India's Troika Of Good Luck | Joining The Dots
A weaker Trump, a cooling AI trade and resilient earnings have put Indian markets back in favour. Rising inflation could spoil the party.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.